Page last updated: 2024-12-10

peridinin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

peridinin: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5289155
CHEMBL ID1980535
SCHEMBL ID135779
MeSH IDM0065778

Synonyms (14)

Synonym
2(5h)-furanone, 5-(11-(4-(acetyloxy)-2-hydroxy-2,6,6-trimethylcyclohexylidene)-2,9-dimethyl-2,4,6,8,10-undecapentaenylidene)-3-(2-(4-hydroxy-2,2,6-trimethyl-7-oxabicyclo(4.1.0)hept-1-yl)ethenyl)-, (1s-(1alpha(e(5z(2e,4e,6e,8e,11(1s*,2s*,4r*)))),4alpha,6al
nsc-679586
NSC679586 ,
peridinin
33281-81-1
LMPR01070007
DB03001
[(1s,3r)-3-hydroxy-4-[(3e,5e,7e,9e,11z)-11-[4-[(e)-2-[(1r,3s,6s)-3-hydroxy-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-6-yl]ethenyl]-5-oxofuran-2-ylidene]-3,10-dimethylundeca-1,3,5,7,9-pentaenylidene]-3,5,5-trimethylcyclohexyl] acetate
SCHEMBL135779
CHEMBL1980535 ,
(1s,3r,4r)-3-hydroxy-4-{(3e,5e,7e,9e,11z)-11-[4-{(e)-2-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl]ethenyl}-5-oxofuran-2(5h)-ylidene]-3,10-dimethylundeca-1,3,5,7,9-pentaen-1-ylidene}-3,5,5-trimethylcyclohexyl acetate
DTXSID20903948
Q2080033
bdbm50525245

Research Excerpts

Overview

Peridinin is a light-harvesting carotenoid present in phototrophic dinoflagellates. It has great potential for new drug applications and cosmetics development.

ExcerptReferenceRelevance
"Peridinin is a light-harvesting carotenoid present in phototrophic dinoflagellates and has great potential for new drug applications and cosmetics development. "( Light induces peridinin and docosahexaenoic acid accumulation in the dinoflagellate Durusdinium glynnii.
Abreu, JL; Bezerra, RS; Gálvez, AO; Matos, ÂP; Müller, MN; Oliveira, CDL; Oliveira, CYB; Santos, EP; Tribuzi, G; Veras, BO, 2022
)
2.52
"Peridinin is a light-harvesting carotenoid found in oceanic photosynthetic organisms. "( Syntheses of ylidenbutenolide-modified derivatives of peridinin and their stereochemical and spectral characteristics.
Aoki, K; Frank, HA; Iwashita, T; Kajikawa, T; Katsumura, S; Niedzwiedzki, DM, 2010
)
2.05
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Genome polyproteinDengue virus 2 Thailand/16681/84EC50 (µMol)6.99204.20006.60868.5000AID1599288; AID1599289; AID1599290; AID1599401; AID1847515
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID1599399Antiviral activity against DENV3 infected in mouse RAW 264.7 cells by MTT assay2019European journal of medicinal chemistry, Aug-15, Volume: 176Recent update on anti-dengue drug discovery.
AID1599288Inhibition of DENV2 NS2B-NS3 serine protease expressed in human Huh7 cells after 3 days by luciferase reporter gene assay2019European journal of medicinal chemistry, Aug-15, Volume: 176Recent update on anti-dengue drug discovery.
AID1599398Antiviral activity against DENV2 infected in mouse RAW 264.7 cells by MTT assay2019European journal of medicinal chemistry, Aug-15, Volume: 176Recent update on anti-dengue drug discovery.
AID1847511Antiviral activity against DENV2 infected in human Huh-7 cells assessed as inhibition of viral replication measured after 72 hrs post infection by qRT-PCR analysis2021Bioorganic & medicinal chemistry, 11-01, Volume: 49A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases.
AID1599400Antiviral activity against DENV4 infected in mouse RAW 264.7 cells by MTT assay2019European journal of medicinal chemistry, Aug-15, Volume: 176Recent update on anti-dengue drug discovery.
AID1847513Antiviral activity against DENV3 infected in human Huh-7 cells assessed as inhibition of viral replication measured after 72 hrs post infection by qRT-PCR analysis2021Bioorganic & medicinal chemistry, 11-01, Volume: 49A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases.
AID1599401Inhibition of Dengue virus NS2B-NS3 serine protease expressed in mouse RAW 264.7 cells2019European journal of medicinal chemistry, Aug-15, Volume: 176Recent update on anti-dengue drug discovery.
AID1599397Antiviral activity against DENV1 infected in mouse RAW 264.7 cells by MTT assay2019European journal of medicinal chemistry, Aug-15, Volume: 176Recent update on anti-dengue drug discovery.
AID1599289Inhibition of DENV1 NS2B-NS3 serine protease expressed in human Huh7 cells after 3 days by luciferase reporter gene assay2019European journal of medicinal chemistry, Aug-15, Volume: 176Recent update on anti-dengue drug discovery.
AID1847512Antiviral activity against DENV1 infected in human Huh-7 cells assessed as inhibition of viral replication measured after 72 hrs post infection by qRT-PCR analysis2021Bioorganic & medicinal chemistry, 11-01, Volume: 49A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases.
AID1847515Inhibition of DENV NS2B/NS3 protease transfected in human Huh-7 cells treated for 3 days by nano-glo luciferase assay2021Bioorganic & medicinal chemistry, 11-01, Volume: 49A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases.
AID1599290Inhibition of DENV4 NS2B-NS3 serine protease expressed in human Huh7 cells after 3 days by luciferase reporter gene assay2019European journal of medicinal chemistry, Aug-15, Volume: 176Recent update on anti-dengue drug discovery.
AID1847522Antiviral activity against DENV2 assessed as inhibition of viral replication2021Bioorganic & medicinal chemistry, 11-01, Volume: 49A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases.
AID1847514Antiviral activity against DENV4 infected in human Huh-7 cells assessed as inhibition of viral replication measured after 72 hrs post infection by qRT-PCR analysis2021Bioorganic & medicinal chemistry, 11-01, Volume: 49A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (128)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (2.34)18.7374
1990's8 (6.25)18.2507
2000's42 (32.81)29.6817
2010's64 (50.00)24.3611
2020's11 (8.59)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.96 (24.57)
Research Supply Index4.90 (2.92)
Research Growth Index5.28 (4.65)
Search Engine Demand Index48.05 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other126 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]